Cargando…

Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA

OBJECTIVES: The objective of this study is to assess the prevalence of treatment with radiotherapy and/or chemotherapy in the general adult population of five countries (Brazil, China, France, Russia and the USA) and to evaluate the use of different Supportive Care in Cancer (SCC) services. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Buiret, Guillaume, Delvigne, Véronique, le Dantec, Guénaëlle, Guyonnet‐Debersac, Pascale, Taïeb, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787726/
https://www.ncbi.nlm.nih.gov/pubmed/35708175
http://dx.doi.org/10.1111/ecc.13636
_version_ 1784858581424668672
author Buiret, Guillaume
Delvigne, Véronique
le Dantec, Guénaëlle
Guyonnet‐Debersac, Pascale
Taïeb, Charles
author_facet Buiret, Guillaume
Delvigne, Véronique
le Dantec, Guénaëlle
Guyonnet‐Debersac, Pascale
Taïeb, Charles
author_sort Buiret, Guillaume
collection PubMed
description OBJECTIVES: The objective of this study is to assess the prevalence of treatment with radiotherapy and/or chemotherapy in the general adult population of five countries (Brazil, China, France, Russia and the USA) and to evaluate the use of different Supportive Care in Cancer (SCC) services. METHODS: A total of 11,100 individuals representing the general population over 18 years of age were recruited from the five countries via a rigorous quota sampling method. RESULTS: There are between 4.1% and 8.78% of respondents reported having undergone medical cancer treatment. Among these subpopulations, the use of at least one SCC was reported by 63% to 86% of respondents. The most commonly used SCC was psychological counselling in France, dietary counselling in Brazil and China, participating in a focus group in the USA and using alternative medicine in Russia. Alternative medicines were chosen by 50% to 61% of patients in every country. CONCLUSION: This study provides information on the prevalence of patients treated by chemotherapy and/or radiotherapy in representative populations from five countries. Among them, SCC was widely used. However, these uses varied both in proportion and choice, given the cultural differences in patients' and families' health beliefs and values, differences among organisations, in available resources and in ethics and policies among countries.
format Online
Article
Text
id pubmed-9787726
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97877262022-12-28 Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA Buiret, Guillaume Delvigne, Véronique le Dantec, Guénaëlle Guyonnet‐Debersac, Pascale Taïeb, Charles Eur J Cancer Care (Engl) Original Articles OBJECTIVES: The objective of this study is to assess the prevalence of treatment with radiotherapy and/or chemotherapy in the general adult population of five countries (Brazil, China, France, Russia and the USA) and to evaluate the use of different Supportive Care in Cancer (SCC) services. METHODS: A total of 11,100 individuals representing the general population over 18 years of age were recruited from the five countries via a rigorous quota sampling method. RESULTS: There are between 4.1% and 8.78% of respondents reported having undergone medical cancer treatment. Among these subpopulations, the use of at least one SCC was reported by 63% to 86% of respondents. The most commonly used SCC was psychological counselling in France, dietary counselling in Brazil and China, participating in a focus group in the USA and using alternative medicine in Russia. Alternative medicines were chosen by 50% to 61% of patients in every country. CONCLUSION: This study provides information on the prevalence of patients treated by chemotherapy and/or radiotherapy in representative populations from five countries. Among them, SCC was widely used. However, these uses varied both in proportion and choice, given the cultural differences in patients' and families' health beliefs and values, differences among organisations, in available resources and in ethics and policies among countries. John Wiley and Sons Inc. 2022-06-16 2022-11 /pmc/articles/PMC9787726/ /pubmed/35708175 http://dx.doi.org/10.1111/ecc.13636 Text en © 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Buiret, Guillaume
Delvigne, Véronique
le Dantec, Guénaëlle
Guyonnet‐Debersac, Pascale
Taïeb, Charles
Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
title Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
title_full Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
title_fullStr Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
title_full_unstemmed Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
title_short Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
title_sort prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in brazil, china, france, russia and the usa
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787726/
https://www.ncbi.nlm.nih.gov/pubmed/35708175
http://dx.doi.org/10.1111/ecc.13636
work_keys_str_mv AT buiretguillaume prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa
AT delvigneveronique prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa
AT ledantecguenaelle prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa
AT guyonnetdebersacpascale prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa
AT taiebcharles prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa